420 with CNW – Minnesota Expands Medical Cannabis Program

On Monday, the Health Department in Minnesota announced that come 2020, residents of the state suffering from chronic pain and age-related macular degeneration would be qualified to register for the medical marijuana program.

The Health Department also approved two delivery methods to give patients the option to choose from. The two systems include water-soluble cannabinoid multi-particles such as powders, granules, and sprinkles, and orally dissolvable products such as gums, mints, lozenges, buccal pills, and sublingual tablets.

Earlier this year, the lawmakers passed a law permitting the medical marijuana manufacturers for the program to double the number of marijuana treatment centers accessible by patients. The number of centers will be eight, making medical marijuana products more accessible to patients.

One of the medical marijuana manufacturers is Leafline Labs, and they suggested treatment centers to be set up at Willmar, Mankato, Golden Valley, and Rogers. Minnesota Medical Solution is the other manufacturing company, and it has proposed centers to be located at Woodbury, Blaine, Duluth, and Burnsville.

The Health Commissioner in Minnesota, Jan Malcolm, said that the increase in treatment centers and delivery methods would give patients more options, especially with the potential health impact of vaping.

In a statement, Malcolm further said that she is hopeful that with the new delivery methods, patients will have an alternative way of using medical marijuana, and the treatment centers will be easily accessible. The state’s program is a bit strict as it does not allow patients to access cannabis in leaf form or consume it through smoking. And before, patients could only access weed in the form of liquid gel, topical ointment, pills, and vape products.

Malcolm also said that the department added chronic pain to the list of qualifying conditions after reviewing the positive evidence where people have been using medical pot to treat intractable pain. She also noted that the age-related macular degeneration was added to the list after the agency found no other viable options for managing the symptoms.

The policy director for Sensible Change Minnesota, Maren Schroeder, said that doctors have been slow in certifying intractable pain since it carries a particular legal definition whereby it should be pain that cannot be cured but only managed, and other treatment options have failed to relieve the symptoms.

Patients identified to be suffering from chronic pain or age-related macular degeneration qualify to register with the medical marijuana program come July 1, 2020. They will be able to access medical marijuana treatment from manufacturers in the state on August 1.

The medical marijuana program in Minnesota started in 2014, when the state’s Department of Health approved only nine qualifying conditions.

In October 2019, approximately 18,000 patients were registered with the state’s medical marijuana program. The expansion of the program is seen by analysts as a move that will address some of the concerns of the entire industry, such as IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), since the expanded program allows more patients to benefit.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000